PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsSarfez Pharmaceuticals
Sarfez Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
SoaanzTorsemide2021-06-142033
Heart failure
,
Hypertension
,
Chronic kidney failure
,
Liver cirrhosis
,
Nephrotic syndrome
,
Edema
,
Ascites
,
Pulmonary edema
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Torsemide
malnutrition
,
therapeutic equivalency
,
type 2 diabetes mellitus
,
diabetes mellitus
,
biotransformation
,
food-drug interactions
,
body weight
,
body weight changes
,
disease
,
pre-eclampsia
,
overactive urinary bladder
,
urinary incontinence
,
healthy volunteers/patients
,
genetic predisposition to disease
,
heart failure
,
hypertension
,
edema
,
chronic renal insufficiency
,
kidney diseases
,
renal insufficiency
,
cardiovascular diseases
,
tricuspid valve insufficiency
,
fibrosis
,
mitral valve insufficiency
,
covid-19
,
drug-related side effects and adverse reactions
,
drug interactions
Spirolactone
healthy volunteers/patients
,
diabetic nephropathies
,
kidney diseases
,
heart failure
,
type 2 diabetes mellitus
,
diabetes mellitus
,
glucose intolerance
,
hypertension
,
hypercholesterolemia
Isoxaflutole
healthy volunteers/patients
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use